Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Nervous System Fungal Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01889836
What this trial is testing

Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos

Who this might be right for
Meningitis, Meningococcal, Serogroup C
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 60
Not applicableLooking for participantsNCT06680011
What this trial is testing

Cohort-Based Study of Diagnostic Biomarkers for Neurosyphilis

Who this might be right for
NeurosyphilisBiomarkersProteomics
Shanghai Mental Health Center 360
Not applicableUnknownNCT02328469
What this trial is testing

Aseptic Meningoencephalitis in Slovenia

Who this might be right for
Aseptic Meningitis
University Medical Centre Ljubljana 800
Large-scale testing (Phase 3)Study completedNCT01341639
What this trial is testing

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

Who this might be right for
Bacterial InfectionsVirus Diseases
MCM Vaccines B.V. 1,250
Large-scale testing (Phase 3)Study completedNCT01802385
What this trial is testing

Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis

Who this might be right for
Cryptococcal MeningitisFungal Meningitis
University of Minnesota 460
Large-scale testing (Phase 3)Study completedNCT01148017
What this trial is testing

Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Novartis Vaccines 433
Not applicableUnknownNCT03898635
What this trial is testing

Retrospective Real-word Study of Linezolid for the Treatment of Tuberculous Meningitis

Who this might be right for
Tuberculous Meningitis
Huashan Hospital 150
Not applicableLooking for participantsNCT05641116
What this trial is testing

Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis.

Who this might be right for
Lyme BorreliosisPhysical ActivityLyme Borreliosis, Nervous System
Centre Hospitalier Universitaire de Saint Etienne 62
Early research (Phase 1)Study completedNCT00293345
What this trial is testing

3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+56 more
National Cancer Institute (NCI) 30
Not applicableStudy completedNCT00830856
What this trial is testing

Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa

Who this might be right for
Cryptococcal MeningitisHIV Infections
University of Zimbabwe 54
Large-scale testing (Phase 3)Study completedNCT00329901
What this trial is testing

Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,072
Not applicableStudy completedNCT00855855
What this trial is testing

Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease

Who this might be right for
Haemophilus InfectionsDiphtheriaTetanus+2 more
Sanofi Pasteur, a Sanofi Company 20,830
Testing effectiveness (Phase 2)Study completedNCT00436618
What this trial is testing

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Mayo Clinic 277
Large-scale testing (Phase 3)Study completedNCT00453570
What this trial is testing

Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

Who this might be right for
DiphtheriaTetanusHaemophilus Influenzae Type b+2 more
Sanofi 792
Testing effectiveness (Phase 2)Study completedNCT03433482
What this trial is testing

Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,707
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Large-scale testing (Phase 3)Study completedNCT01457560
What this trial is testing

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine

Who this might be right for
Hepatitis BAcellular PertussisHaemophilus Influenzae Type b+3 more
GlaxoSmithKline 80
Post-approval studies (Phase 4)Study completedNCT01546909
What this trial is testing

Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

Who this might be right for
DiphtheriaTetanusPoliomyelitis
Sanofi Pasteur, a Sanofi Company 278
Large-scale testing (Phase 3)Study completedNCT02986854
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 704
Not applicableStudy completedNCT00005496
What this trial is testing

Inflammation, Infection, and Future Cardiovascular Risk

Who this might be right for
Cardiovascular DiseasesCoronary DiseaseCerebrovascular Accident+9 more
National Heart, Lung, and Blood Institute (NHLBI)
Next Page